SCHEMBL15782801

SCHEMBL15782801

CCc1ccc(O)cc1C(C)=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B1 P14061 2/20 0.58
CA12 O43570 5/20 0.46
CA1 P00915 5/20 0.46
CA2 P00918 5/20 0.46
CA7 P43166 5/20 0.46
CA9 Q16790 5/20 0.46
CA14 Q9ULX7 5/20 0.46
HSP90AB1 P08238 1/20 0.46
ALDH1A1 P00352 1/20 0.44
CYP3A4 P08684 1/20 0.44
HPGD P15428 1/20 0.44
MAPK1 P28482 1/20 0.44
ALOX15 P16050 1/20 0.43
ALOX12 P18054 1/20 0.43
KDM4E B2RXH2 1/20 0.42
MEN1 O00255 1/20 0.42
S1PR4 O95977 1/20 0.42
GLA P06280 1/20 0.42
GAA P10253 1/20 0.42
MAPT P10636 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16863862 0.86 PRKCI (0.50) HSD17B1CA12CA1CA2CA7
SCHEMBL11202540 0.84 HSD17B1 (0.46) HSD17B1CA12CA1CA2CA7
SCHEMBL18598996 0.83 TYR (0.61) HSD17B1CA12CA1CA2CA7
SCHEMBL1995440 0.83 CA12 (0.57) HSD17B1CA12CA1CA2CA7
SCHEMBL8271835 0.83 HSD17B1 (0.73) HSD17B1CA12CA1CA2CA7
SCHEMBL16311335 0.82 HSD17B1 (0.43) HSD17B1CA12CA1CA2CA7
SCHEMBL8160238 0.79 HSD17B1 (0.44) HSD17B1ALDH1A1HPGDALOX15ALOX12
SCHEMBL4677431 0.79 HSD17B1 (0.44) HSD17B1ALOX15ALOX12KDM4EMEN1
SCHEMBL2318550 0.79 CA12 (0.65) CA12CA1CA2CA7CA9
SCHEMBL14466515 0.79 ALDH1A1 (0.58) ALDH1A1CYP3A4HPGDMAPK1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3138831-A1 SYNTHESIS OF TETRACYCLINES AND ANALOGUES THEREOF President and Fellows of Harvard College (US) 2017-03-08 EP disclosed
US-9365493-B2 Synthesis of tetracyclines and analogues thereof PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2016-06-14 US disclosed
EP-1973901-B1 HYDANTOIN DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY DISORDERS MERCK SHARP & DOHME (US) 2014-12-17 EP disclosed
US-20140163238-A1 SYNTHESIS OF TETRACYCLINES AND ANALOGUES THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2014-06-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140163238-A1 SYNTHESIS OF TETRACYCLINES AND ANALOGUES THEREOF TET1, TET3, MYC HSD17B1 1662/4885CA12 4122/4885CA1 4408/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.